Global Dialysis Market - 2022-2029

Global Dialysis Market - 2022-2029

Market Overview

Dialysis Market size was valued US$ 87.02 billion in 2021 and is estimated to reach US$ 194.83 billion by 2029, growing at a CAGR of 6.5% during the forecast period (2022-2029).

In medicine, dialysis is the process of removing excess water, solutes, and toxins from the blood in people whose kidneys can no longer perform these functions naturally. This is referred to as renal replacement therapy.

As dialysis has expanded, its delivery model has changed drastically. Dialysis was once performed exclusively in hospitals. But now hundreds of thousands of patients have their blood cleansed in anonymous storefronts, industrial parks, and homes, and a large majority of the dialysis services delivered globally are expected to turn a profit.

Market Dynamics

The dialysis market growth is driven by several factors including, the rising patients with ESRD condition, increasing prevalence of diabetes and hypertension, technological advancements, and new product launches.

Increasing prevalence of diabetes and rising technological advancements are expected to drive the market growth.

Increasing number of ESRD patients is primarily driving the global dialysis market and is anticipated to remain the same over the forecast period. End-Stage Renal Disease also referred to as kidney failure is the last stage of chronic kidney disease. According to National Kidney Foundation, 10% of the population worldwide is affected by chronic kidney disease (CKD), millions die each year, and over 2 million people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive, yet this number may only represent 10% of people who actually need treatment to live.

According to ERCPA, at the end of 2019, there were around 3.7 million patients being treated for end-stage renal disease (ESRD) worldwide and expected to increase by approximately 6% each year, which is significantly higher than the population growth rate. Out of those 3.7 million patients, almost 3 million were undergoing dialysis treatment

The increasing prevalence of diabetes and hypertension is boosting the global dialysis market. High blood glucose, also called blood sugar, can damage the blood vessels in the kidneys and when the blood vessels are damaged, kidneys don't work as well. According to World Health Organization, it is estimated that approximately 40 percent of people worldwide have been affected by blood pressure. 46 percent of adults aged 25 and older are expected to suffer from hypertension over the forecast period.

Shortage of organ donors, technological advancements and rising R&D expenditure for developing new dialysis products are further driving the global dialysis market.

Risks associated with dialysis is expected to hamper the market growth.

The risks and complications associated with dialysis that can be fatal are hampering the market over the forecast period. High cost associated with these treatments is also impacting the market growth. Alternate options available in market such as kidney transplant that are efficient and most opted can restrain the growth of market

Industry Analysis

The global dialysis market provides in-depth analysis of the market based on various industry factors such as porter’s five forces, regulatory analysis, supply chain analysis, pricing analysis and unmet needs.

Global Dialysis Market - Segment Analysis

Hemodialysis segment is expected to hold the largest market share in global dialysis market

Based on type, dialysis type global dialysis market is segmented into hemodialysis and peritoneal dialysis. Hemodialysis accounted for the largest share in the global dialysis market due to the increasing number of patients treated with hemodialysis. According to the University of California San Francisco, in the United States, nearly 750,000 patients per year in the United States and an estimated 2 million patients worldwide are affected by end-stage renal disease and 90% of them are treated with hemodialysis.

For instance, on July 16, 2019, CVS Kidney Care launched HemoCare Hemodialysis System, this innovative device includes unique safety features and is designed to make home hemodialysis simpler for patients.

Peritoneal dialysis uses the patient’s own abdomen across which waste is exchanged from the blood and flushed out regularly through a permanent tube in the abdomen. Peritoneal dialysis does not require regular trips to a medical facility but still requires regular treatment at home.

Based on end-user, global dialysis market is categorized into home care, hospitals, dialysis centers, and others. Dialysis centers hold the largest market share in the global dialysis market. According to the Clinical Journal of American Society of Nephrology, in 2019, in United States, the number of dialysis facilities in the United States increased by 54%.

Geographical Analysis

North America region holds the largest market share in the global dialysis market

As per the research study, the global market is divided into majorly five regions such as North America, South America, Europe, the Middle East, Africa, Asia Pacific, and the Rest of the world.

North America dominates the global dialysis due to increasing number of dialysis centers and an increasing number of ESRD patients. According to the University of California San Francisco, ESRD is increasing in the United States by 5% per year. This shows the requirement for dialysis in North America. Most of the major key players are present in this particular region making it the largest market share holder. Various new product launches and innovations are also increasing the market in the region. In Mar 2022, B. Braun announced its acquisition of Intermedt Medizin and Technik GmbH, company that is specialized in dialysis concentrates preparation.

Europe holds the second largest market due to the increasing number of kidney failure cases. According to European Renal Association, in Europe, 329,000 patients received a total of 49.8 million HD treatments across 5,410 centers and expected to increase at 3% each year.

Asia Pacific is registering the fastest CAGR due to the increasing number of manufacturers and key market players in this region. Various novel technological advancements and latest product launches are taking place in countries such as India, China, and Japan. This factor will drive the growth of market in this region.

Competitive Landscape

The key players in dialysis market are Asahi Kasei Medical Co., Ltd, Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Nipro Corporation, NIKKISO Co. Ltd, Rockwell Medical, Inc, Toray Medical Co., Ltd, Davita Inc, Diaverum, Dialife Group, Fresenius Medical Care AG & Co. KGaA.

Companies are focusing on key strategies such as collaboration, acquisitions, and product launches which are boosting the growth of the market globally. For instance,

• In Mar 2022, Fresenius SE & Co. & Interwell Health and Cricket Health merged and formed a new company that is going to operate as InterWell Health brand. They are going to focus on the products and services of initial phases of kidney disease.

• In Oct 2021, Baxter, acute care provider together with bioMerieux, in-vitro diagnostics company announced that Nephroclear CCL14 test received CE mark. It is developed to forecast persistent severe acute kidney injury.

• In Jun 2021, Baxter, innovator in renal care and acute care provider launched Sharesource Analytics 1.0 module, digital health new generation for home dialysis patients. It is a platform for clinical patient management.

• On July 16, 2019, CVS Kidney Care launched HemoCare Hemodialysis System, this innovative device includes unique safety features and is designed to make home hemodialysis simpler for patients.

• On January 18, 2019, Fresenius Medical Care launched a 4008A dialysis machine tailored to needs in emerging markets.

Global Dialysis Market – Key Companies to Watch

Baxter International Inc.:

Overview: Baxter is a multinational American healthcare company that primarily manufactures products and provides services related to kidney disease treatment and various medical acute & chronic conditions. It was founded in 1931 and is headquartered in Illinois, Unites States.

Product Portfolio:

Artis Physio Plus: It is a multiple therapy system that provides combines effective HD, efficient HDF and HDx therapies that gives proper control across the delivery for treatment of personalised hemodialysis. It provides simple and fast treatment delivery.

Key Developments: In Apr 2022, Baxter, company providing acute care announced the clearance of ST Set by U.S. Food and Drug Administration. ST Set is a disposable, pre-connected, extracorporeal system that purifies the blood via semipermeable membrane used with control units. It is used in continuous renal replacement therapy.

The global dialysis market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.